Neutralising antibodies to interferon beta during the treatment of multiple sclerosis
Neutralising antibodies to interferon beta during the treatment of multiple sclerosis
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
ANTIBODIES ELICITED BY INTERFERON BETA An immune response against protein based drugs is not unusual. 6 For example, neutralising antibodies have been reported during treatment with interferon alfa for viral hepatitis B and C, hairy cell leukaemia, and other types of cancer, 9, 10 during treatment with bovine or porcine insulin for diabetes mellitu...
Alternative Titles
Full title
Neutralising antibodies to interferon beta during the treatment of multiple sclerosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1738139
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1738139
Other Identifiers
ISSN
0022-3050
E-ISSN
1468-330X
DOI
10.1136/jnnp.73.5.465
